PMCC Staff Publications

pmcc logo sml


 Here are the staff publications for September 2021.

Compiled by the Health Sciences Library (RMH, RWH, PMCC & Victorian Mental Health) 5th October 2021.


  1. Alipour R, Bucknell N, Bressel M, et al. Nodal metabolic tumour volume on baseline (18) F-FDG PET/CT and overall survival in stage II and III NSCLC patients undergoing curative-intent chemoradiotherapy/radiotherapy. J Med Imaging Radiat Oncol 2021;65:748-54.

  2. Bagaria SP, Swallow C, Suraweera H, et al. Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group. Ann Surg Oncol 2021;28:6882-9.

  3. Bean HR, Diggens J, Ftanou M, Weihs KL, Stanton AL, Wiley JF. Insomnia and Fatigue Symptom Trajectories in Breast Cancer: A Longitudinal Cohort Study. Behav Sleep Med 2021;19:814-27.

  4. Beaumont S, Harrison S, Er J. Review of Myeloma Therapies and Their Potential for Oral and Maxillofacial Side Effects. Cancers (Basel) 2021;13.

  5. Bergholtz H, Carter JM, Cesano A, et al. Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx(®) Digital Spatial Profiler. Cancers (Basel) 2021;13.

  6. Bergin K, Wellard C, Augustson B, et al. Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR). Bone Marrow Transplant 2021;56:2533-43.

  7. Boyle S, Wellard C, Moore EM, et al. Receiving four or fewer cycles of therapy predicts poor survival in newly diagnosed transplant-ineligible patients with myeloma who are treated with bortezomib-based induction. Eur J Haematol 2021;107:497-9.

  8. Campbell BA, Lasocki A, Oon SF, et al. Evaluation of the Impact of Magnetic Resonance Imaging with Susceptibility-weighted Imaging for Screening and Surveillance of Radiation-induced Cavernomas in Long-term Survivors of Malignancy. Clin Oncol (R Coll Radiol) 2021;33:e425-e32.

  9. Caparica R, Bruzzone M, Agostinetto E, et al. Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysis. Breast 2021;59:183-92.

  10. Chan D, Kaplan J, Gordon G, Desai J. Activity of the Gamma Secretase Inhibitor AL101 in Desmoid Tumors: A Case Report of 2 Adult Cases. Curr Oncol 2021;28:3659-67.

  11. Cheng C, Zhang D, Dang D, et al. The incubation period of COVID-19: a global meta-analysis of 53 studies and a Chinese observation study of 11 545 patients. Infect Dis Poverty 2021;10:119.

  12. Choo N, Ramm S, Luu J, et al. High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids. SLAS Discov 2021;26:1107-24.

  13. Copaescu A, Choshi P, Pedretti S, Mouhtouris E, Peter J, Trubiano JA. Corrigendum: Dose Dependent Antimicrobial Cellular Cytotoxicity-Implications for ex vivo Diagnostics. Front Pharmacol 2021;12:758192.

  14. Dao NV, Ercole F, Li Y, et al. Nitroxide-functional PEGylated nanostars arrest cellular oxidative stress and exhibit preferential accumulation in co-cultured breast cancer cells. J Mater Chem B 2021;9:7805-20.

  15. Deftereos I, Yeung JM, Arslan J, et al. Preoperative Nutrition Intervention in Patients Undergoing Resection for Upper Gastrointestinal Cancer: Results from the Multi-Centre NOURISH Point Prevalence Study. Nutrients 2021;13.

  16. Elliott J, Avdic S, Selim AG, et al. An atypical case of Epstein-Barr virus-positive plasma cell post-transplant lymphoproliferative disorder successfully treated with adoptive cell therapy. Br J Haematol 2021;195:140-3.

  17. Emens LA, Adams S, Barrios CH, et al. Corrigendum to 'First-line atezolizumab plus nab-paclitaxel for unresectable locally advanced or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis': Annals of Oncology 2021; volume 32: 983-993. Ann Oncol 2021;32:1308.

  18. Flood M, Narasimhan V, Waters P, et al. Survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A systematic review and discussion of latest controversies. Surgeon 2021;19:310-20.

  19. Fortuno C, Pesaran T, Dolinsky J, et al. An updated quantitative model to classify missense variants in the TP53 gene: A novel multifactorial strategy. Hum Mutat 2021;42:1351-61.

  20. Frowen J, Gough K, Hughes R, et al. Functional and patient-reported changes in swallowing and voice after combined chemotherapy and radiotherapy for limited-stage small-cell lung cancer. J Med Imaging Radiat Oncol 2021;65:786-95.

  21. Gosavi R, Chia C, Michael M, Heriot AG, Warrier SK, Kong JC. Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review and meta-analysis. Int J Colorectal Dis 2021;36:2063-70.

  22. Gould C, Lickiss J, Kankanige Y, et al. Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target. Br J Haematol 2021;195:113-8.

  23. Heckler M, Ali LR, Clancy-Thompson E, et al. Inhibition of CDK4/6 Promotes CD8 T-cell Memory Formation. Cancer Discov 2021;11:2564-81.

  24. Hilbers ML, Dimitriou F, Lau P, et al. Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases. Eur J Cancer 2021;156:149-63.

  25. Hochheiser K, Gyorki DE, Gebhardt T. Tumor reactivity of CD8(+) T cells favors acquisition of dysfunctional states in human melanoma. Immunol Cell Biol 2021;99:914-6.

  26. Hofman MS, Louw L, Pacak K, Taïeb D. The Global Reading Room: Nuclear Medicine Imaging of Suspected Paraganglioma. AJR Am J Roentgenol 2021;217:1008-9.

  27. Hyatt A, Drosdowsky A, Koproski T, et al. Identification of low health and cancer literacy in oncology patients: a cross-sectional survey. Support Care Cancer 2021;29:6605-12.

  28. Jayasekara H, MacInnis RJ, Juneja S, et al. Smoking, alcohol consumption, body fatness, and risk of myelodysplastic syndromes: A prospective study. Leuk Res 2021;109:106593.

  29. Jerusalem G, Farah S, Courtois A, et al. Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy. Ann Oncol 2021;32:1256-66.

  30. Johnatty SE, Pesaran T, Dolinsky J, et al. Case-case analysis addressing ascertainment bias for multigene panel testing implicates BRCA1 and PALB2 in endometrial cancer. Hum Mutat 2021;42:1265-78.

  31. Khoury AL, Keane H, Varghese F, et al. Trigger point injection for post-mastectomy pain: a simple intervention with high rate of long-term relief. NPJ Breast Cancer 2021;7:123.

  32. Kiss NK, Denehy L, Edbrooke L, et al. Predicting muscle loss during lung cancer treatment (PREDICT): protocol for a mixed methods prospective study. BMJ Open 2021;11:e051665.

  33. Koldej RM, Prabahran A, Tan CW, Ng AP, Davis MJ, Ritchie DS. Dissection of the bone marrow microenvironment in hairy cell leukaemia identifies prognostic tumour and immune related biomarkers. Sci Rep 2021;11:19056.

  34. Korte JC, Cardenas C, Hardcastle N, et al. Author Correction: Radiomics feature stability of open-source software evaluated on apparent diffusion coefficient maps in head and neck cancer. Sci Rep 2021;11:18908.

  35. Korte JC, Cardenas C, Hardcastle N, et al. Radiomics feature stability of open-source software evaluated on apparent diffusion coefficient maps in head and neck cancer. Sci Rep 2021;11:17633.

  36. Kuzich JA, Kankanige Y, Guinto J, et al. T cell receptor beta locus sequencing early post-allogeneic stem cell transplant identifies patients at risk of initial and recurrent cytomegalovirus infection. Bone Marrow Transplant 2021;56:2582-90.

  37. Lelliott EJ, Kong IY, Zethoven M, et al. CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory. Cancer Discov 2021;11:2582-601.

  38. Lodge W, Zavortink M, Golenkina S, et al. Tumor-derived MMPs regulate cachexia in a Drosophila cancer model. Dev Cell 2021;56:2664-80.e6.

  39. Loi S, Michiels S, Adams S, et al. The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition. Ann Oncol 2021;32:1236-44.

  40. Louie AV, Tjong MC, Siva S. Surgery versus SABR for early-stage lung cancer-time to call it a draw? Lancet Oncol 2021;22:1355-7.

  41. Ma S, Seymour JF, Brander DM, et al. Efficacy of venetoclax plus rituximab for relapsed CLL: 5-year follow-up of continuous or limited- duration therapy. Blood 2021;138:836-46.

  42. Maharaj AD, Evans SM, Zalcberg JR, et al. Barriers and enablers to the implementation of multidisciplinary team meetings: a qualitative study using the theoretical domains framework. BMJ Qual Saf 2021;30:792-803.

  43. Manoharan N, Ajuyah P, Senapati A, et al. Diffuse leptomeningeal glioneuronal tumour (DLGNT) in children: the emerging role of genomic analysis. Acta Neuropathol Commun 2021;9:147.

  44. McDowell LJ. In the Hot Seat. Int J Radiat Oncol Biol Phys 2021;111:307-8.

  45. Mueller SN, Sloan EK. Neuroimmune interactions at the crossroads of health and disease. Immunol Cell Biol 2021;99:922-3.

  46. Murali K, Dwarte TM, Nikfarjam M, et al. Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants. Hered Cancer Clin Pract 2021;19:37.

  47. Murnane A, Kiss N, Fraser SF, Lewin J. Health-related quality of life, fatigue and health behaviours in Australian adolescent and young adult cancer survivors. Pediatr Blood Cancer 2021;68:e29243.

  48. Nedumannil R, Sim S, Westerman D, Juneja S. Identification and quantitation of blasts in myeloid malignancies with marrow fibrosis or marrow hypoplasia and CD34 negativity. Pathology 2021;53:795-8.

  49. Nesic K, Kondrashova O, Hurley RM, et al. Acquired RAD51C Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma. Cancer Res 2021;81:4709-22.

  50. Ong SY, Schuelein R, Wibawa RR, et al. Genome-wide genetic screen identifies host ubiquitination as important for Legionella pneumophila Dot/Icm effector translocation. Cell Microbiol 2021;23:e13368.

  51. Ong WL, Weerasinghe C. Radiation oncology training in Australia and New Zealand during and beyond the COVID-19 pandemic - lessons learnt and opportunities for improvement. J Med Imaging Radiat Oncol 2021;65:826-8.

  52. Ost P, Siva S, Zilli T. Everything But the Kitchen Sink: Comprehensive Nodal Irradiation with Androgen Deprivation in OLIGOPELVIS. Eur Urol 2021;80:415-6.

  53. Papa N, Perera M, Murphy DG, et al. Patterns of primary staging for newly diagnosed prostate cancer in the era of prostate specific membrane antigen positron emission tomography: A population-based analysis. J Med Imaging Radiat Oncol 2021;65:649-54.

  54. Pascoe MC, Bailey AP, Craike M, et al. Poor reporting of physical activity and exercise interventions in youth mental health trials: A brief report. Early Interv Psychiatry 2021;15:1414-22.

  55. Pasricha SR, Hasan MI, Braat S, et al. Benefits and Risks of Iron Interventions in Infants in Rural Bangladesh. N Engl J Med 2021;385:982-95.

  56. Perera SM, O'Callaghan C, Ugalde A, et al. Codesigning a supportive online resource for Australian cancer carers: a thematic analysis of informal carers' and healthcare professionals' perspectives about carers' responsibilities and content needs. BMJ Open 2021;11:e055026.

  57. Post CCB, Stelloo E, Smit V, et al. Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer. J Natl Cancer Inst 2021;113:1212-20.

  58. Reynolds G, Haeusler G, Slavin MA, Teh B, Thursky K. Latent infection screening and prevalence in cancer patients born outside of Australia: a universal versus risk-based approach? Support Care Cancer 2021;29:6193-200.

  59. Roberts AW, Wei AH, Huang DCS. BCL2 and MCL1 inhibitors for hematologic malignancies. Blood 2021;138:1120-36.

  60. Sandhu S, Moore CM, Chiong E, Beltran H, Bristow RG, Williams SG. Prostate cancer. Lancet 2021;398:1075-90.

  61. Schepers AG, Shan J, Cox AG, et al. Identification of NQO2 As a Protein Target in Small Molecule Modulation of Hepatocellular Function. ACS Chem Biol 2021;16:1770-8.

  62. Schuster SJ, Tam CS, Borchmann P, et al. Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study. Lancet Oncol 2021;22:1403-15.

  63. Sia J, Hagekyriakou J, Chindris I, et al. Regulatory T Cells Shape the Differential Impact of Radiation Dose-Fractionation Schedules on Host Innate and Adaptive Antitumor Immune Defenses. Int J Radiat Oncol Biol Phys 2021;111:502-14.

  64. Sim HW, McDonald KL, Lwin Z, et al. A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study. Neuro Oncol 2021;23:1736-49.

  65. Teoh JY, Castellani D, Mercader C, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Eur Urol 2021;80:442-9.

  66. Teoh JY, Murphy DG, van Oort IM, Loeb S, Ribal MJ. Reply to Laurence Klotz's Letter to the Editor re: Jeremy Yuen-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Eur Urol 2021;80:442-9. Eur Urol 2021;80:e101.

  67. Terry RL, Meyran D, Fleuren EDG, et al. Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric Sarcoma. Cancers (Basel) 2021;13.

  68. Wang J, Wuethrich A, Lobb RJ, et al. Characterizing the Heterogeneity of Small Extracellular Vesicle Populations in Multiple Cancer Types via an Ultrasensitive Chip. ACS Sens 2021;6:3182-94.

  69. Xie J, Kumar A, Dolman MEM, et al. The important role of routine cytopathology in pediatric precision oncology. Cancer Cytopathol 2021;129:805-18.

  70. Yanase F, Tosif SH, Churilov L, et al. A Randomized, Multicenter, Open-Label, Blinded End Point, Phase 2, Feasibility, Efficacy, and Safety Trial of Preoperative Microvascular Protection in Patients Undergoing Major Abdominal Surgery. Anesth Analg 2021;133:1036-47.

  71. Yeoh DK, Moore AS, Kotecha RS, et al. Invasive fungal disease in children with acute myeloid leukaemia: An Australian multicentre 10-year review. Pediatr Blood Cancer 2021;68:e29275.

  72. Zelli V, Silvestri V, Valentini V, et al. Transcriptome of Male Breast Cancer Matched with Germline Profiling Reveals Novel Molecular Subtypes with Possible Clinical Relevance. Cancers (Basel) 2021;13.

  73. Zhang QY, Yan ZB, Meng YM, et al. Antimicrobial peptides: mechanism of action, activity and clinical potential. Mil Med Res 2021;8:48.